Correlation Between AN2 Therapeutics and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on AN2 Therapeutics and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Corbus Pharmaceuticals.
Diversification Opportunities for AN2 Therapeutics and Corbus Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between AN2 and Corbus is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Corbus Pharmaceuticals
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Corbus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, AN2 Therapeutics is 2.21 times less risky than Corbus Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Corbus Pharmaceuticals Holding is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 686.00 in Corbus Pharmaceuticals Holding on August 26, 2024 and sell it today you would earn a total of 1,061 from holding Corbus Pharmaceuticals Holding or generate 154.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| AN2 Therapeutics |
| Corbus Pharmaceuticals |
AN2 Therapeutics and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Corbus Pharmaceuticals
The main advantage of trading using opposite AN2 Therapeutics and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |